ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008

BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors and angiotens in receptor blockers (ARBs) are widely prescribed for the treatment of hypertension and heart failure, as well as for kidney disease prevention inpatients with diabetes mellitus and the management of patients after myocardialin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Boyang, Kelton, Christina M.L., Guo, Jeff J., Wigle, Patricia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437572/
https://www.ncbi.nlm.nih.gov/pubmed/21067253
http://dx.doi.org/10.18553/jmcp.2010.16.9.671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437572/
https://www.ncbi.nlm.nih.gov/pubmed/21067253
http://dx.doi.org/10.18553/jmcp.2010.16.9.671

Ejemplares similares